| Dear Voornaam,
Welcome to your weekly Cancer Research UK Research Update email.
Today, we’re delighted to welcome our new chief scientist, KJ Patel.
KJ has worked closely with Cancer Research UK throughout his career and brings substantial expertise and scientific leadership to the role. He is Director of the MRC Weatherall Institute of Molecular Medicine and the MRC Molecular Haematology Unit at the University of Oxford, having spent most of his research career at the MRC Laboratory of Molecular Biology in Cambridge.
Much of his research has focused on endogenous DNA damage, and his findings have contributed to greater understanding of what drives cancer development, such as how alcohol exposure can cause cancer, opening new opportunities for prevention, detection and treatment.
He joins us at an important time, following the launch of our refreshed research strategy which puts discovery science and excellence at the heart of everything we do.
Please join me in welcoming KJ and read our Q&A where he talks about his life, his work and why he’s joining Cancer Research UK.
Kind regards
Iain
Iain Foulkes
Executive Director Research & Innovation
CEO Cancer Research Horizons
Cancer Research UK
|
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
PROFESSOR DAME VALERIE BERAL Many of you may have heard that Professor Dame Valerie Beral has died. Val was an eminent cancer epidemiologist with longstanding links to Cancer Research UK.
Among her many scientific achievements, Valerie produced compelling evidence that cervical cancer was due to a sexually transmitted infection (nearly 10 years before HPV was found to be the cause of most cervical cancers). She established the link between HIV infection and an increased risk of Kaposi’s sarcoma. Valerie set up and led the groundbreaking Million Women Study – the largest prospective study of women’s health anywhere in the world – and published extensively on the links between oral contraceptives, HRT and cancer risk. |
|
|---|
|
|---|
|
|
APPLICATIONS OPEN FOR BLACK LEADERS IN CANCER PHD We’re now welcoming applications for our Black Leaders in Cancer PhD Scholarship Programme, developed in partnership with Black in Cancer and Windsor Fellowship to help empower the next generation of Black cancer researchers.
The scheme offers fully funded, 4-year PhD studentships in cancer research plus personal and professional support including training and mentoring. Applications are open until 10 November for positions based at our City of London Centre and until 15 November for our Cambridge Centre. |
|
|---|
| ARE YOU AN ENTREPRENEURIALLY MINDED EARLY-CAREER RESEARCHER? Cancer Research Horizons Innovation & Entrepreneurship Awards 2022 is showcasing early entrepreneurial talent. If you are, or know of, an early-career cancer researcher who has shown entrepreneurial initiative and attitude, submit your nomination for our Early-career Entrepreneur of the Year Award.
The judges will look for nominees who have developed their entrepreneurial skills through participation in training or entrepreneurial programmes.
Discover more about our awards and our other categories and nominate yourself or a peer by 28 October for the opportunity to receive sector-wide recognition, and to inspire the next generation of entrepreneurs. |
|
|---|
|
|---|
|
|
CELEBRATING CANCER RESEARCH NURSING AT THE RCN AWARDS 2022 Last week saw Jo Hargroves, CRUK senior research nurse from University College London Hospital, take home the Excellence in Cancer Research Nursing Award at the Royal College of Nursing’s 2022 Nursing Awards.
The awards recognise the very best in nursing across the UK and this category specifically celebrates the daily innovative practice, skills and expertise of nurses who deliver high-quality cancer research studies and help patients access novel treatments and care.
We spoke to Jo about her work to support staff new to clinical research with the fundamentals and complexities of running clinical cancer trials. Other finalists also told us about their shortlisted projects, including the setup of a new patient trials advocate service, running new multi-centre studies, expanding patient access to cancer trials, and streamlining the long-term follow up pathway for patients. |
|
|---|
|
|---|
|
|
APPLICATIONS OPEN FOR THE FRANCIS CRICK INSTITUTE PHD FOR CLINICIANS The Francis Crick Institute is welcoming applications for its 2023 doctoral fellowships for clinicians.
This is an excellent opportunity for a talented clinician passionate about research to perform biomedical discovery research while following a three-year clinical PhD programme – applications are open until 15 November 2022. |
|
|---|
| JOINING OUR FUTURE HEALTH We’re pleased to announce that we’re joining Our Future Health as a new affiliate member.
Our Future Health is a collaboration between the public, charity and private sectors to build the UK’s largest health research programme. By working together, they hope to develop new ways to prevent, detect and treat cancer and other diseases. |
|
|---|
|
|---|
|
|
| | | Amsterdam, Netherlands 14 October 2022 |
|
|---|
|
|---|
| | | Portland, Oregon, USA 18 October 2022 |
|
|---|
|
|---|
| | | Manchester, UK 15 November 2022 |
|
|---|
|
|---|
| | | East Sussex, UK 04 December 2022 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
